¡@¡@Although the Bio-pharmaceutical industry in Taiwan is less then 1% in worldwide medical market¡CAlmost 150 Bio-pharmaceutical companies in Taiwan were met the cGMP standard, yet limited on the R&D human resources and the capital size ¡Amost of the companies all focus on the manufacturing of Generic products. ¡@¡@As the Internationalize and Globalize were mainstreams for all Pharmaceutical industries. We need to take this into consideration that how we increase Taiwan¡¦s competitiveness, and win out over the other industry in the international alliance. And should we improve any weakness? Efficiency, Inventory, or customer needs?¡@¡@ ¡@¡@So far¡Mbecause of the conflict of the Regulation requirements¡M. Most Bio-industry was not using the ERP/SCM for the management¡C In this study¡MWe hope to provide an actual example for the other Bio-industry as reference¡Mand then as an application model to improve the competitiveness of Taiwan Bio-pharmaceutical industry.¡@¡@ ¡@¡@During the dissertation, we discover the monograph rational of ERP/SCM, and consider the regulation limited when follow the SCM model to analyze the process suitability and performance for Bio-pharmaceutical Company. ¡@¡@As result, we know that the ERP/MRP-II system or Supply chain management was necessary to the Bio-pharmaceutical industry.